A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease

NCT06909799 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

242

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis (TB)

Interventions

DRUG: N-Acetyl Cysteine (NAC)
DRUG: Standard TB treatment

Sponsor

The Aurum Institute NPC

Collaborators

[object Object]
[object Object]